China, Sept. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A retrospective study on efficacy and safety of conversion ablation therapy for hepatocellular carcinoma'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600131431
Registration Time: 2026/09/02
Type: Observational study
Primary Sponsor: The Fifth Medical Center of Chinese PLA General Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=341015
Published by HT Digital Content Services with permission from Health Daily Digest....